|1.86||+0.12 / +6.90%|
Data as of 3:59pm ET
|1.89||+0.03 / +1.61%|
The 9 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 6.00, with a high estimate of 11.00 and a low estimate of 3.00. The median estimate represents a +222.58% increase from the last price of 1.86.
The current consensus among 9 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.